Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Agenda & Minutes France Typhoid Ebola Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Efficacy/effectiveness All age groups Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Agenda & Minutes New Zealand Haemophilus influenzae type B
Download:
Haemophilus influenzae type B